WENTWORTH TIMOTHY C 4

What Happened
Timothy C. Wentworth, a director of Quest Diagnostics (DGX), was granted 215 shares via a restricted stock unit award on March 9, 2026. The Form 4 reports the acquisition as 215 shares at $0.00 per share (total reported value $0.00), reflecting an award rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-03-09; Form 4 filed: 2026-03-11 (timely filing).
• Transaction type/code: A — Award/Grant.
• Shares involved: 215 restricted stock units (RSUs).
• Price: $0.00 per share as reported; total reported acquisition value $0.00.
• Shares owned after transaction: not specified in this filing.
• Footnote: F1 indicates these are restricted stock units (RSUs), typically subject to vesting.

Context
Restricted stock unit awards are a form of compensation that generally vest over time and do not represent an immediate cash purchase or sale. Such awards align recipients with shareholder value over the vesting period but do not by themselves indicate a market-direction bet.